维普中文期刊产品整合服务
24篇 您的检索式:作者名="ERNSTOFF MS"
    题名 作者 年代 出处 被引量
1ArginaseⅠ-producing myeloid-derived suppressor cells in renal cell carcinoma are a subpopulation of activated granulocytes显示文摘Rodriguez PC Ernstoff MS Hernandez C 2009Cancer Res2009,69,4:1
2Arginase I-producing myeloid-derived suppressor cells in renal cell carcinoma are a subpopulation of activated granulocytes 显示文摘Rodriguez PC Ernstoff MS Hernandez C 2009Cancer Res2009,69,4:1
3Adjuvant therapy of stage III and IV malignant melanoma using granulocyte-macrophage colonystimulating factor显示文摘Spitler LE Groddbard ML Ernstoff MS 2008J Clin Oncol2008,18,8:1
4Pegylated interferon alfa-2b treatment for patients with solid tumors: a phase Ⅰ/Ⅱ study显示文摘BUKOWSKI R ERNSTOFF MS GORE ME 2002J Clin Oncol2002,20,18:1
5Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma:the Eastern Cooperative Oncology Group Trial EST 1684显示文摘Kirkwood JM Strawderman MH Ernstoff MS 1996Clinic Oncol1996,14,1:1
6Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684 显示文摘Kirkwood JM Strawderman MH Ernstoff MS 1996J Clin Oncol1996,14,1:1
7Adjuvanttherapy of stage Ⅲ and Ⅳ malignant melanoma using granulocyte ̄marcophage colony ̄stimulating factor 显示文摘 Grossbard ML Ernstoff MS 2000JCO2000,18,:1
8Ipilimumab in patients with melanoma and brain metastases:an open- label, phase 2 trial 显示文摘Margolin K Ernstoff MS Hamid O 2012Lancet Oncol2012,13,5:1
9Interferon alpha-2b adjuvant therapy of high-risk resected cutaneous melanoma显示文摘Kirkwood JM Strawderman MH Ernstoff MS 1996J Clin Oncol1996,14,:1
10Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: The Eastern Cooperative Oncology Group Trial EST 1684 显示文摘Kirkwood JM Strawderman MH Ernstoff MS 1996J Clin Oncol1996,14,1:1
11Pegylated inter-feron a - 2b treatment for patients with solid tumors: a phase Ⅰ / Ⅱ study显示文摘Bukowski R Ernstoff MS Gore ME 2002J Clin 0neol2002,20,18:1
12Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma:the Eastern Cooperative Oncology Group Trial EST 1684显示文摘Kirkwood JM Strawderman MH Ernstoff MS 1996J Clin Oncol1996,14,1:1
13A phase 1 study of a vaccine targeting preferentially expressed antigen in melanoma and prostate-specific membrane antigen in patients with advanced solid tumors显示文摘Weber JS Vogelzang NJ Ernstoff MS 2011J Immunother2011,34,7:1
14Arginase 1-producingmyeloid derived suppressor ceils in renal cell carcinoma are a subpopulation of activated granulocytes显示文摘Rodriguez PC Ernstoff MS Hernandez C 2009Cancer Res2009,69,:1
15Arginase I-producing myeloid-derived suppressor cells in renal cell carcinoma are a subpopulation of activated granulocytes显示文摘Rodriguez PC Ernstoff MS Hernandez C 2009Cancer Res2009,69,4:1
16Arginase I-producing myeloid- derived suppressor cells in renal cell carcinoma are asubpopulation of activated granulocytes显示文摘Rodriguez PC Ernstoff MS Hernandez C 2009Cancer Res2009,69,4:1
17Developing a rational tumor vaccine therapy for renal cell carcinoma: immune yin and yang显示文摘Ernstoff MS Crocenzi TS Seigne JD 2007Clin Cancer Res2007,13,:1
18Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: The Eastern Cooperative Oncology Group Trial EST 1684 显示文摘Kirkwood 1M Strawderman MH Ernstoff MS 19961 Clin Oncol1996,14,1:1
19Arginase I-producing myeloid-derived suppressor cells in renal cell carcinoma are a subpopulation of activated granulocytes显示文摘RODRIGUEZ PC ERNSTOFF MS HERNANDEZ C 2009Cancer Res2009,69,4:1
20Arginase I-producing myeloid-derived suppressor cells in renal cell carcinoma are a subpopulation of activated granulocytes显示文摘Rodriguez PC Ernstoff MS Hernandez C 2009Cancer Res2009,69,4:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费